Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

FlyteHealth vs Gimme Care

FlyteHealth
Graded #364

Lower grade

vs+25.999999999999993
Gimme Care
Graded #23

Higher grade

The verdict

Gimme Care takes it — 84.6/100 to 58.6/100.

Gimme Care grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mid-value both-molecule pricing ($130/$163), verified, and nationwide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueGimme Care +44
45
89
Dose & formulationGimme Care +40
40
80
Clinical oversightGimme Care +1
83
84
Labs & monitoringGimme Care +9
73
82
FulfillmentGimme Care +25
62
87
Contract termsGimme Care +30
55
85
FlyteHealth · left barGimme Care · right bar

The numbers

MetricFlyteHealthGimme Care
WeighScore58.6/10084.6/100
GradeCB
Scorecard rank#364#23
SemaglutideNot disclosed$130/mo
TirzepatideNot disclosed$163/mo
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
FlyteHealth

Graded #364 · C

Strengths

  • Care led by board-certified obesity-medicine physicians
  • Multidisciplinary team with NPs, dietitians, and care coordinators
  • Published outcomes of about 13 to 16 percent weight loss over 12 months
  • High GLP-1 medication adherence (around 86 percent in reported data)
  • Comprehensive cardiometabolic care beyond GLP-1 alone

Where it loses points

  • Distributed primarily via employers, payers, and health plans, not direct cash-pay
  • Access is largely gated behind employer or plan sponsorship
  • GLP-1 is prescribed only when appropriate, not guaranteed
  • Self-pay pricing is not publicly listed (contact required)
  • Less suited to consumers wanting fast direct-to-door GLP-1
Gimme Care

Graded #23 · B

Strengths

  • $130 sema / $163 tirz
  • All 50 states, LegitScript-verified
  • Both molecules

Where it loses points

  • Not the cheapest tier
  • Injection-only
  • Monitoring detail limited

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard